ROS1
Drug: Crizotinib
Cancer code: GBM
Cancer type: glioma
Drug treatment table
| Cell line ID |
Cell line name |
Mutation in substructure |
IC50(uM) |
| SIDM00867 | DBTRG-05MG | A_loop (2126) | 560.1637 |
| SIDM00998 | 8-MG-BA | None | 18.2338 |
| SIDM00581 | GB-1 | None | 8.0895 |
| SIDM01189 | U-87-MG | None | 13.5883 |
| SIDM00095 | SNB75 | None | 44.6386 |
| SIDM00085 | SF268 | None | 17.9954 |
| SIDM00490 | Becker | None | 2.3909 |
| SIDM00555 | KS-1 | None | 2.6174 |
| SIDM00382 | SF126 | None | 16.5181 |
| SIDM00492 | AM-38 | None | 21.0092 |
| SIDM00212 | CAS-1 | None | 28.5623 |
| SIDM00622 | D-247MG | None | 15.2755 |
| SIDM00732 | D-263MG | None | 35.3361 |
| SIDM00982 | 42-MG-BA | None | 29.7484 |
| SIDM00998 | 8-MG-BA | None | 17.3664 |
| SIDM00799 | A172 | None | 39.1727 |
| SIDM00581 | GB-1 | None | 108.9402 |
| SIDM01171 | T98G | None | 34.2894 |
| SIDM01193 | U-118-MG | None | 35.7319 |
| SIDM01189 | U-87-MG | None | 68.8064 |
| SIDM00111 | U251 | None | 111.0879 |
| SIDM00085 | SF268 | None | 75.541 |
| SIDM00490 | Becker | None | 15.7007 |
| SIDM00947 | DK-MG | None | 8.7199 |
| SIDM01074 | GMS-10 | None | 28.9098 |
| SIDM00555 | KS-1 | None | 29.295 |
| SIDM00379 | SK-MG-1 | None | 81.036 |
| SIDM01155 | SW1088 | None | 75.5669 |
| SIDM00316 | YH-13 | None | 7.4669 |
| SIDM00343 | LN-405 | None | 150.2819 |
| SIDM00492 | AM-38 | None | 4.0219 |
| SIDM00212 | CAS-1 | None | 158.6339 |
| SIDM00732 | D-263MG | None | 50.7411 |
| SIDM00542 | D-392MG | None | 31.38 |
| SIDM00659 | M059J | None | 28.9975 |
| SIDM00685 | LN-18 | None | 39.2981 |
| SIDM00684 | LN-229 | None | 88.7951 |